Skip to main content
MediciNova,Inc. logo

MediciNova,Inc. — Investor Relations & Filings

Ticker · 4875 ISIN · US58468P2065 T Manufacturing
Open in API
Filings indexed 59 across all filing types
Latest filing 2022-06-10 Audit Report / Informat…
Country JP Japan
Listing T 4875

About MediciNova,Inc.

https://medicinova.com/

MediciNova, Inc. is a clinical-stage biopharmaceutical company that acquires and develops novel, small-molecule therapeutics. The company's late-stage pipeline focuses on addressing unmet medical needs in neurology, respiratory, and liver diseases. Key development programs include MN-166 (ibudilast) for neurological conditions, MN-001 (tipelukast) for fibrotic diseases such as liver fibrosis (NASH) and pulmonary fibrosis (IPF), and MN-221 for respiratory conditions including acute exacerbations of asthma and COPD.

Recent filings

Filing Released Lang Actions
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Kakuninsho' (Confirmation Letter) filed under the Financial Instruments and Exchange Act of Japan. This specific document is a mandatory attachment to an Annual Securities Report (Yukashoken Hokokusho) in Japan, where the CEO and CFO certify the accuracy of the report's contents. Since it is a regulatory filing required by law to accompany the annual report but is not the annual report itself, and does not fit into other specific categories like 'RPA' or '10-K', it falls under the 'Regulatory Filings' (RNS) category as a fallback for miscellaneous regulatory documents. FY 2021
2022-06-10 Japanese
有価証券報告書
Annual Report Classification · 100% confidence The document is a comprehensive annual filing for MediciNova, Inc. It includes an 'Independent Registered Public Accounting Firm' audit report, detailed financial statements, and a cover page explicitly titled '有価証券報告書' (Securities Report), which is the Japanese equivalent of a 10-K filing. It covers the fiscal year ending December 31, 2021, and provides extensive corporate information, business risks, and financial analysis. It is not an announcement or a summary, but the full report itself. FY 2021
2022-06-10 Japanese
四半期報告書
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by MediciNova, Inc. with the Kanto Local Finance Bureau in Japan. It contains detailed financial data, including balance sheets, income statements, and cash flow statements for the quarterly period ending September 30, 2021. It also includes management's discussion and analysis of the company's business and financial condition. This fits the definition of an Interim/Quarterly Report (IR). Q3 2021
2021-12-10 Japanese
四半期報告書
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by MediciNova, Inc. with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, management analysis, and business information for the fiscal period from April 1, 2021, to June 30, 2021. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data and analysis for a period shorter than a full fiscal year. Q2 2021
2021-09-10 Japanese
四半期報告書
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by MediciNova, Inc. with the Kanto Local Finance Bureau in Japan. It contains detailed financial data, including balance sheets, income statements, and cash flow statements for the quarterly period ending March 31, 2021. It also includes management's discussion and analysis of the business and financial condition. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial statements and analysis for a period shorter than a full fiscal year. Q1 2021
2021-06-14 Japanese
内部統制報告書
Audit Report / Information Classification · 100% confidence The document contains an 'Audit Report of Independent Registered Public Accounting Firm' (BDO USA, LLP) regarding internal control over financial reporting, followed by an 'Internal Control Report' (内部統制報告書) filed with the Kanto Local Finance Bureau in Japan. These documents are specific audit-related disclosures concerning internal controls and financial reporting standards, which fall under the category of Audit Report / Information. FY 2020
2021-06-10 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.